Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive form of lung disease of
unknown etiology for which a paucity of therapies suggest benefit, and for which none have …

Recognising recent advances, the definition and diagnostic criteria for acute exacerbation of
idiopathic pulmonary fibrosis (AE-IPF) have been updated by an international working …

The goal of this review is to summarise the clinical features, management, and prognosis of
acute exacerbations of idiopathic pulmonary fibrosis (AE-IPF). AE-IPF has previously been …

Acute exacerbation is a major cause of morbidity and mortality in patients with idiopathic
pulmonary fibrosis. Although the real nature of it is still not clear and there is no proven …

Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive fibrotic disease limited to the
lung, with high variability in the course of disease from one patient to another. Patients with …

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive and ultimately fatal disease, with
a highly variable course in individual patients. Episodes of rapid deterioration are not …

Introduction: Idiopathic pulmonary fibrosis (IPF), the most common of the idiopathic
interstitial pneumonias, is a disease with a poor prognosis, and a highly heterogeneous and …

Acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) is an often deadly complication
of IPF. No focussed international guidelines for the management of AE-IPF exist. The aim of …

Acute exacerbations of idiopathic pulmonary fibrosis (AE-IPF), with an annual incidence up
to 20% and a short-term mortality around 50%, are the more frequent cause of death in …

Acute exacerbation of idiopathic pulmonary fibrosis (IPF) occurs in approximately 10% of IPF
patients annually, and is a leading cause of morbidity and mortality in this disease. Although …